Our Team

In order to develop our complex, breakthrough technology, we recruited some of the country’s leading scientists in acoustic engineering, plasma physics and immunology who have supported the US Space Program, the nuclear fusion industry and even cancer research. Our technology has also been enabled by design partnerships with GE and Sanmina (the world’s largest medical device manufacturer).

Clinically Focused

We’re committed to holding our technology and its applications to the highest scientific standards, including ongoing clinical trials for current and future applications.  We also believe in education and transparency, and as you’ll see in our trials section, we explain what makes up a comprehensive clinical trial, and showcase our data. We continue to conduct clinical trials for cellulite and tattoo removal and we are expanding our clinical trial activities to include cellulite and other aesthetic indications.

Explore our technology and roadmap: Learn More

Management Team

Walter V. Klemp

Walter V. Klemp | Co-Founder and Executive Chairman  Wally Klemp is an experienced and successful entrepreneur with 30 years of company-building history. He has founded multiple Houston-based biotech companies collaborating with MD Anderson Cancer Center, including Moleculin Biotech, Inc, which he took public in 2016 . He has focused the last 15 years on developing and marketing therapeutic devices and drugs from concept through FDA approval. Prior to that, Mr. Klemp was founder, CEO and Chairman of Drypers Corporation, a publicly traded multinational consumer products company, growing Drypers from start-up to nearly $500 million in annualized sales and #1 on the INC 500 List of America’s Fastest Growing Companies, and earning the American Marketing Association’s Gold Edison Award. He developed growth strategies, orchestrated mergers and acquisitions, and had direct responsibility for nearly $.75 billion in public and private financings.

Brad Hauser

Brad Hauser | President and CEO Mr. Hauser has a well-established reputation in the aesthetics industry and his extensive knowledge of the aesthetic market stems from his many years of valuable industry experience. Mr. Hauser held a number of positions including Senior Vice President of Research and Development and Vice President of Product and Clinical Strategy for CoolSculpting at Allergan since ZELTIQ was acquired in April 2017. He joined the CoolSculpting team in 2013, as Vice President of Product and Clinical Strategy, and later became Senior Vice President of Research and Development. Previously, Mr. Hauser held multiple leadership roles in the aesthetic industry, including Executive Vice President of Commercial Operations at Cutera, Director of Research and Development at Medicis, and Managing Director of Product and Clinical Marketing at Solta Medical. Mr. Hauser received his Bachelor of Arts in Human Biology from Stanford University. Mr. Hauser received his Bachelor of Arts in Human Biology from Stanford University. He joined Soliton’s Board of Directors in June 2018.

Christopher Capelli

Christopher Capelli, M.D. | Vice Chairman, Chief Science Officer and Co-founder Dr. Capelli is the lead inventor of Soliton’s RAP technology. Chris led the Office of Technology Based Ventures at The University of Texas M.D. Anderson Cancer Center where he formed the foundational concepts that have become RAP and eventually left MD Anderson to co-found Soliton. Prior to MD Anderson, Dr. Capelli served the director of the Office of Technology Management at the University of Pittsburgh. Both an MIT engineer and a medical doctor, Chris is the inventor of numerous patents. He was the founder of BioInterface Technologies, Inc., which developed new a silver-based antimicrobial technology for use in wound care, and he was co-inventor of the core technology that eventually became Dexcom, an $8 billion medical device company.

Lori Bisson

Lori Bisson | Executive Vice President and Chief Financial Officer   Prior to joining Soliton, Ms. Bisson worked as a financial and business development consultant advising a number of life science companies. Lori served as the CFO of Zeno Corporation, a medical device company focused on new technology in the aesthetics area, and previously held various positions with Drypers Corporation, a publicly traded multinational consumer products company, where she ultimately held the title of Vice President of Integrated Solutions and oversaw accounting, information technology, and logistics for the US operation. Lori began her career at Arthur Andersen, LLP as an auditor focused on consumer products companies.

Joe Tanner

Joe Tanner | Chief Operating Officer In addition to being a lawyer and having served as a Washington State Senator, Mr. Tanner has served as Chief Operating Officer of Zeno Corporation, a company that developed and marketed dermatology devices and drugs from concept through FDA approval and market launch. Prior to that, Joe has held senior leadership positions in the contract electronics manufacturing industry as well as the consumer products industry, with responsibilities for both domestic and international operations.

Science Advisory Board

* Members of the CoolSculpting (Zeltiq) Medical Advisory Board

Michael Kaminer
Mathew Avram
Roy Geronomus
Elizabeth Tansy
Christopher Zachary
Jeffrey Dover
Victor Ross
Sachin M. shridarani

Independent Directors

Danika Harrison

Danika Harrison: Ms. Harrison has been the Chief Marketing Officer of HintMD since May 2019.  Prior to that she was the President and CEO of Elira Therapeutics, Inc. from September 2017 through May 2019. Prior to that she served as Senior Vice President of Global Marketing at ZELTIQ Aesthetics, Inc. from January 2017, serving as its Vice President of Global Marketing from February 2016 and as VP of Consumer and Brand Marketing from November 2014. Ms. Harrison served as Senior Vice President of Direct Marketing & Innovation at TRIA Beauty, Inc. from December 2013 to June 2014, serving previously as Senior Vice President of Global Marketing from December 2011, and as VP/GM of North America from March 2011. From April 2006 to March 2011, Ms. Harrison worked at Rosetta, a consulting-centered interactive agency, where she was most recently a Partner leading the relationship marketing group consulting for leading brands like Dannon, Johnson’s Baby and Rogers to develop direct and digital marketing programs throughout the United States and Canada. Ms. Harrison holds a B.S. from Georgetown University and an M.B.A. from the Kellogg School of Management at Northwestern University.

Jonathan Foster:

Jonathan Foster: Mr. Foster currently serves as the Chief Financial Officer for Moleculin Biotech, Inc. (MBI), a drug development company traded on the Nasdaq Exchange developing novel cancer therapies.  Prior to his tenure at MBI, Mr. Foster served as the CFO of InfuSystem Holdings, Inc., a medical technology company producing pumps for hospital use, from 2012 to 2016.  Prior to InfuSystem, Mr. Foster served as a consultant to the Chief Financial Officer of LSG Sky Chefs, USA, Inc., a subsidiary of Deutsche Lufthansa AG. Prior to that, from 2000-2012, he was President, CFO and majority owner of United Credit, Inc. & Advance Today, Inc., a privately-owned consumer finance company with multiple locations. From 1996-2000, Mr. Foster served as Executive Vice President and Chief Financial Officer of Drypers Corporation.  He previously served as Chief Financial Officer of Dickson Weatherproof Nail Company, Controller & Treasurer of divisions of Schlumberger Industries, and as a Manager in the Middle Market Group of Deloitte & Touche. He has also served on the State of South Carolina Board of Financial Institutions and the Board of Directors for the Easley Baptist Hospital Foundation.  Mr. Foster has a BS in Accounting from Clemson University, is a Certified Public Accountant and AICPA Chartered Global Management Accountant.

Niquette Hunt

Niquette Hunt: Niquette Hunt is an entrepreneur and successful executive with over 25 years of general management experience. Coming out of line management in both large corporations and start-ups (P&G, Warner Lambert, Revance Therapeutics, Amira Medical) Ms. Hunt has proven her ability to drive significant growth on a variety of businesses across multiple industries. She has successfully launched over twenty new products and every brand she has managed has increased in sales, market share and/or profits under her watch. She founded Candesant Biomedical in 2016 with the goal of alleviating the suffering of the 84 million people in the US who sweat too much. Prior to founding Candesant Biomedical, Ms. Hunt served as the Senior Vice President of Commercial Development for Revance Therapeutics (NASDAQ: RVNC) which she joined in 2009.

Dr. Michael Kaminer

Dr. Michael Kaminer: Dr. Michael Kaminer has over twenty years of experience in the dermatology industry. Currently, he practices at SkinCare Physicians in Chestnut Hill, MA, where he was one of the co-founders. He is currently Associate Clinical Professor of Dermatology, Yale Medical School, and Adjunct Assistant Professor of Medicine (Dermatology) at Brown Medical School. Dr. Kaminer also also holds hospital appointments at Beth Israel Deaconess Medical Center and New England Baptist Hospital. He possesses an abundance of editorial and publication experience, including one of the leading cosmetic surgery books, Atlas of Cosmetic Surgery. Dr. Kaminer has been named as a Top Doctor in Boston for over 10 years.

Stay Up To Date

Sign up below to follow our story and to watch us grow!